Research ArticleCORONAVIRUS

MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program

See allHide authors and affiliations

Science Advances  01 Jan 2021:
Vol. 7, no. 1, eabb6075
DOI: 10.1126/sciadv.abb6075

Article Information

vol. 7 no. 1

PubMed: 
Online ISSN: 
History: 
  • Received for publication March 6, 2020
  • Accepted for publication October 29, 2020
  • .

Article Versions

Author Information

  1. Yi Wang1,*,
  2. Lei Zhang1,*,
  3. Guo-Rao Wu1,
  4. Qing Zhou1,
  5. Huihui Yue1,
  6. Li-Zong Rao1,2,
  7. Ting Yuan1,2,
  8. Biwen Mo2,
  9. Fa-Xi Wang1,
  10. Long-Min Chen1,
  11. Fei Sun1,
  12. Jia Song1,
  13. Fei Xiong1,
  14. Shu Zhang1,
  15. Qilin Yu1,
  16. Ping Yang1,
  17. Yongjian Xu1,
  18. Jianping Zhao1,
  19. Huilan Zhang1,,
  20. Weining Xiong1,3, and
  21. Cong-Yi Wang1,
  1. 1The Center for Biomedical Research, NHC Key Laboratory of Respiratory Diseases, Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Sciences and Technology, 1095 Jiefang Ave., Wuhan 430030, China.
  2. 2Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Guilin Medical University, 212 Renmin Road, Guilin 541000, China.
  3. 3Department of Respiratory Medicine, Shanghai Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine, 639 Zhizaoju Lu, Shanghai 200011, China.
  1. Corresponding author. Email: wangcy{at}tjh.tjmu.edu.cn (C.-Y.W.); xiongdoctor{at}qq.com (W.X.); huilanz_76{at}163.com (H.Z.)
  • * These authors contributed equally to this work.

Altmetric

Article usage

Article usage: December 2020 to April 2021

AbstractFullPdf
Dec 20201264109544
Jan 20212003787966
Feb 2021881319228
Mar 2021481320276
Apr 20212552078

Stay Connected to Science Advances

Navigate This Article